pENTR-THT
(Plasmid
#55790)
-
Purpose(Empty Backbone) GATEWAY cloning compatible conditional shRNA expression vector; TetO flanked H1 RNA gene promoter; Kanamycin resistance
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 55790 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepENTR-1A
-
Backbone manufacturerInvitrogen
- Backbone size (bp) 2500
-
Modifications to backboneintroduction of TetO-flanked H1 promoter stuffer between BglII/HindIII
-
Vector typeMammalian Expression, RNAi ; GATEWAY
- Promoter modified H1 RNA gene
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Cloning Information
- Cloning method Restriction Enzyme
- 5′ sequencing primer 5'-CTGCAGGAATTCGAACGCTGACG-3' (ON1108)
- 3′ sequencing primer 5'-TGTAAAACGACGGCCAGT-3' (ON980) (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made bypENTR-H1 was obtained from Invitrogen; the H1 RNA gene promoter was a gift from Reuven Agami, NKI, Amsterdam, Netherlands; the Tet07 operator was a gift from Manfred Gossen, MDC, Berlin, Germany.
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
There are some minor discrepancies between the depositor's assembled sequence and Addgene's quality control sequence. These differences should not affect the function of the plasmid.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pENTR-THT was a gift from Stephan Geley (Addgene plasmid # 55790 ; http://n2t.net/addgene:55790 ; RRID:Addgene_55790) -
For your References section:
Development of a Multipurpose GATEWAY-Based Lentiviral Tetracycline-Regulated Conditional RNAi System (GLTR). Sigl R, Ploner C, Shivalingaiah G, Kofler R, Geley S. PLoS One. 2014 May 19;9(5):e97764. doi: 10.1371/journal.pone.0097764. eCollection 2014. 10.1371/journal.pone.0097764 PubMed 24841113